1226776-95-9Relevant articles and documents
PROCESS FOR THE PREPARATION OF SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, INTERMEDIATES AND POLYMORPHS THEREOF
-
Page/Page column 36, (2015/12/08)
The present invention relates to a process for preparation of substituted imidazo[4,5- c]quinoline compounds (the compounds of formula I as described) and intermediates thereof. The present invention also relates to polymorphs of a compound encompassed in the compound of formula I and their use in the treatment of proliferative disorders, particularly cancers.
FUSED HETEROARYLS AND THEIR USES
-
Paragraph 0146; 0150, (2013/07/31)
Provided are certain fused heteroaryls, compositions thereof and methods of use therefor.
FUSED HETEROARYLS AND THEIR USES
-
Page/Page column 31, (2012/04/04)
Provided are certain fused heteroaryls, compositions thereof and methods of use therefor.
SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES AS KINASE INHIBITORS
-
Page/Page column 51, (2012/02/02)
The present invention relates to substituted imidazo[4,5-c]quinoline derivatives, the compounds of formula (I), wherein R1 R2, R3, R4, R5, R6 and R7 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of formula (I), and their use in the treatment of diseases or disorders mediated by one or more kinases, particularly proliferative diseases or disorders such as cancer. These compounds can also be used in the treatment of inflammatory diseases and angiogenesis related disorders.
SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES
-
Page/Page column 43, (2012/06/30)
The present invention relates to substituted imidazo[4,5-c]quinoline derivatives of formula (I), wherein R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of the present invention and their use in the treatment of diseases or disorders mediated by one or more kinases, particularly proliferative diseases or disorders such as cancer. These compounds can also be used in the treatment of inflammation and angiogenesis related disorders.